Novavax Claims Positive Results From Early Trials Of Combination Covid/Flu Vaccine

By Alex Knapp, Forbes Staff in alexknappblog, Breaking, breaking-news, Editors' Pick, Forbes, healthcare, technology
April 20, 2022

The company will be moving into more clinical trials for the vaccine through 2022 and 2023.

Read the full post on Forbes - Healthcare

Alex Knapp, Forbes Staff